Follicular lymphoma grade IIIa, intrathoracic lymph nodes
ICD-10 C82.32 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiia, intrathoracic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIa indicates a more aggressive form of the disease, where there is a predominance of large cells, but still retains some follicular architecture. The involvement of intrathoracic lymph nodes suggests that the lymphoma has spread beyond its original site, which can complicate treatment and prognosis. Patients may present with B-symptoms, which include fever, night sweats, and weight loss, indicating systemic involvement. Diagnosis typically involves imaging studies such as CT scans and biopsy of affected lymph nodes. Treatment options may include chemotherapy, immunotherapy, or radiation therapy, depending on the stage and overall health of the patient. The prognosis for grade IIIa follicular lymphoma can vary, and close monitoring is essential to manage the disease effectively.
Detailed pathology reports, imaging results, and treatment plans.
Diagnosis and management of newly diagnosed lymphoma patients, treatment planning for relapsed disease.
Ensure accurate documentation of disease staging and grading, as well as patient symptoms.
Clear imaging reports indicating lymph node involvement and any changes over time.
CT scans for staging and monitoring response to treatment.
Radiologists should document the size and location of lymph nodes to support accurate coding.
Used for administering chemotherapy to treat follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Common treatments include chemotherapy regimens such as R-CHOP, immunotherapy, and radiation therapy, depending on the patient's overall health and disease stage.
